IL133036A0 - Quinoline-4-carboxamide derivatives as nk-2 and nk-3 receptor antagonists - Google Patents
Quinoline-4-carboxamide derivatives as nk-2 and nk-3 receptor antagonistsInfo
- Publication number
- IL133036A0 IL133036A0 IL13303698A IL13303698A IL133036A0 IL 133036 A0 IL133036 A0 IL 133036A0 IL 13303698 A IL13303698 A IL 13303698A IL 13303698 A IL13303698 A IL 13303698A IL 133036 A0 IL133036 A0 IL 133036A0
- Authority
- IL
- Israel
- Prior art keywords
- quinoline
- receptor antagonists
- carboxamide derivatives
- carboxamide
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
- C07D251/40—Nitrogen atoms
- C07D251/48—Two nitrogen atoms
- C07D251/52—Two nitrogen atoms with an oxygen or sulfur atom attached to the third ring carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9710750.2A GB9710750D0 (en) | 1997-05-23 | 1997-05-23 | Novel compounds |
IT002354 IT1295358B1 (it) | 1997-10-17 | 1997-10-17 | Derivati chinolinici procedimento per la loro preparazione e uso come antagonisti del recettore nk3 |
ITMI972775 IT1296976B1 (it) | 1997-12-16 | 1997-12-16 | Derivati chinolinici procedimento per la loro preparazione e uso come antagonisti del recettore nk3 |
PCT/EP1998/003014 WO1998052942A1 (en) | 1997-05-23 | 1998-05-18 | Quinoline-4-carboxamide derivatives as nk-2 and nk-3 receptor antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
IL133036A0 true IL133036A0 (en) | 2001-03-19 |
Family
ID=27268859
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL13303698A IL133036A0 (en) | 1997-05-23 | 1998-05-18 | Quinoline-4-carboxamide derivatives as nk-2 and nk-3 receptor antagonists |
Country Status (26)
Country | Link |
---|---|
EP (1) | EP0983262B1 (xx) |
JP (1) | JP2002500645A (xx) |
CN (1) | CN1264378A (xx) |
AP (1) | AP9901695A0 (xx) |
AR (1) | AR012732A1 (xx) |
AT (1) | ATE244711T1 (xx) |
AU (1) | AU8209898A (xx) |
BG (1) | BG104009A (xx) |
BR (1) | BR9809652A (xx) |
CA (1) | CA2291111A1 (xx) |
CO (1) | CO4950515A1 (xx) |
DE (1) | DE69816290T2 (xx) |
DZ (1) | DZ2498A1 (xx) |
EA (1) | EA199901062A1 (xx) |
ES (1) | ES2201509T3 (xx) |
HU (1) | HUP0002300A3 (xx) |
ID (1) | ID22876A (xx) |
IL (1) | IL133036A0 (xx) |
MA (1) | MA26501A1 (xx) |
NO (1) | NO995711L (xx) |
OA (1) | OA11515A (xx) |
PE (1) | PE75199A1 (xx) |
PL (1) | PL336942A1 (xx) |
SK (1) | SK159299A3 (xx) |
TR (1) | TR199902883T2 (xx) |
WO (1) | WO1998052942A1 (xx) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6780875B2 (en) * | 1998-11-20 | 2004-08-24 | Smithkline Beecham S.P.A. | Quinoline-4-carboxamide derivatives as NK-3 and NK-2 receptor antagonists |
IL143137A0 (en) * | 1998-11-20 | 2002-04-21 | Smithkline Beecham Spa | Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
GB9825554D0 (en) * | 1998-11-20 | 1999-01-13 | Smithkline Beecham Spa | Novel Compounds |
JP2002540203A (ja) | 1999-03-29 | 2002-11-26 | ニューロゲン コーポレイション | Nk−3および/またはgaba(a)受容体リガンドとしての4−置換キノリン誘導体 |
WO2000064877A1 (en) | 1999-04-26 | 2000-11-02 | Neurogen Corporation | 2-aminoquinolinecarboxamides: neurokinin receptor ligands |
WO2002013825A1 (en) * | 2000-08-11 | 2002-02-21 | Smithkline Beecham P.L.C. | Novel pharmaceutical use of quinnoline derivatives |
JP2004517062A (ja) * | 2000-11-13 | 2004-06-10 | グラクソスミスクライン・ソシエタ・ペル・アチオニ | Nk−3およびnk−2アンタゴニストとしてのキノリン誘導体 |
GB0028964D0 (en) * | 2000-11-28 | 2001-01-10 | Smithkline Beecham Spa | Novel compounds |
WO2002044165A1 (en) * | 2000-11-28 | 2002-06-06 | Glaxosmithkline Spa | Quinoline derivatives as nk-3 antagonists |
US6540733B2 (en) | 2000-12-29 | 2003-04-01 | Corazon Technologies, Inc. | Proton generating catheters and methods for their use in enhancing fluid flow through a vascular site occupied by a calcified vascular occlusion |
DE60209362T2 (de) * | 2001-04-11 | 2006-10-26 | Glaxosmithkline S.P.A. | 3-substituierte chinolin-4-carbonsäureamidderivate als nk-3- und nk-2-rezeptorantagonisten |
GB0109122D0 (en) * | 2001-04-11 | 2001-05-30 | Smithkline Beecham Spa | Novel compounds |
MY134211A (en) * | 2001-05-18 | 2007-11-30 | Smithkline Beecham Corp | Novel use |
GB0425076D0 (en) * | 2004-11-12 | 2004-12-15 | Smithkline Beecham Corp | Novel compounds |
GB0425077D0 (en) * | 2004-11-12 | 2004-12-15 | Smithkline Beecham Corp | Novel compounds |
GB0425075D0 (en) * | 2004-11-12 | 2004-12-15 | Smithkline Beecham Corp | Novel compounds |
US20080200500A1 (en) * | 2005-06-03 | 2008-08-21 | Astrazeneca Ab | Quinoline Derivatives as Nk3 Antagonists |
GB0515580D0 (en) | 2005-07-29 | 2005-09-07 | Merck Sharp & Dohme | Therapeutic compounds |
AR057130A1 (es) | 2005-09-21 | 2007-11-14 | Astrazeneca Ab | Quinolinas de alquilsulfoxido y una composicion farmaceutica |
DE202007017299U1 (de) * | 2007-12-12 | 2009-04-23 | Drebo Werkzeugfabrik Gmbh | Bohrer |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2227769T3 (es) * | 1994-05-27 | 2005-04-01 | Glaxosmithkline S.P.A. | Derivados de quinolina como antagonistas del receptor nk3 de taquiquinina. |
AR004735A1 (es) * | 1995-11-24 | 1999-03-10 | Smithkline Beecham Spa | Quinoleina 4-amido sustituida, un procedimiento para su preparacion, una composicion farmaceutica que los contiene y el uso de los mismos para lapreparacion de un medicamento. |
-
1998
- 1998-05-18 HU HU0002300A patent/HUP0002300A3/hu unknown
- 1998-05-18 CN CN98807356A patent/CN1264378A/zh active Pending
- 1998-05-18 IL IL13303698A patent/IL133036A0/xx unknown
- 1998-05-18 AU AU82098/98A patent/AU8209898A/en not_active Abandoned
- 1998-05-18 AP APAP/P/1999/001695A patent/AP9901695A0/en unknown
- 1998-05-18 JP JP54996798A patent/JP2002500645A/ja not_active Ceased
- 1998-05-18 AT AT98932069T patent/ATE244711T1/de not_active IP Right Cessation
- 1998-05-18 BR BR9809652-4A patent/BR9809652A/pt not_active IP Right Cessation
- 1998-05-18 SK SK1592-99A patent/SK159299A3/sk unknown
- 1998-05-18 ES ES98932069T patent/ES2201509T3/es not_active Expired - Lifetime
- 1998-05-18 WO PCT/EP1998/003014 patent/WO1998052942A1/en not_active Application Discontinuation
- 1998-05-18 ID IDW991432A patent/ID22876A/id unknown
- 1998-05-18 EA EA199901062A patent/EA199901062A1/ru unknown
- 1998-05-18 EP EP98932069A patent/EP0983262B1/en not_active Expired - Lifetime
- 1998-05-18 TR TR1999/02883T patent/TR199902883T2/xx unknown
- 1998-05-18 PL PL98336942A patent/PL336942A1/xx unknown
- 1998-05-18 DE DE69816290T patent/DE69816290T2/de not_active Expired - Fee Related
- 1998-05-18 CA CA002291111A patent/CA2291111A1/en not_active Abandoned
- 1998-05-19 DZ DZ980108A patent/DZ2498A1/xx active
- 1998-05-20 PE PE1998000398A patent/PE75199A1/es not_active Application Discontinuation
- 1998-05-21 AR ARP980102363A patent/AR012732A1/es not_active Application Discontinuation
- 1998-05-21 MA MA25086A patent/MA26501A1/fr unknown
- 1998-05-22 CO CO98029024A patent/CO4950515A1/es unknown
-
1999
- 1999-11-22 NO NO995711A patent/NO995711L/no not_active Application Discontinuation
- 1999-11-23 OA OA9900253A patent/OA11515A/en unknown
- 1999-12-14 BG BG104009A patent/BG104009A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
BG104009A (en) | 2000-07-31 |
TR199902883T2 (xx) | 2000-05-22 |
NO995711D0 (no) | 1999-11-22 |
DE69816290D1 (de) | 2003-08-14 |
AU8209898A (en) | 1998-12-11 |
HUP0002300A3 (en) | 2002-01-28 |
CO4950515A1 (es) | 2000-09-01 |
ES2201509T3 (es) | 2004-03-16 |
CN1264378A (zh) | 2000-08-23 |
DE69816290T2 (de) | 2004-05-27 |
PE75199A1 (es) | 1999-10-22 |
AR012732A1 (es) | 2000-11-08 |
DZ2498A1 (fr) | 2003-01-25 |
MA26501A1 (fr) | 2004-12-20 |
EA199901062A1 (ru) | 2000-08-28 |
EP0983262B1 (en) | 2003-07-09 |
ID22876A (id) | 1999-12-16 |
PL336942A1 (en) | 2000-07-17 |
ATE244711T1 (de) | 2003-07-15 |
CA2291111A1 (en) | 1998-11-26 |
OA11515A (en) | 2004-02-04 |
AP9901695A0 (en) | 1999-12-31 |
JP2002500645A (ja) | 2002-01-08 |
EP0983262A1 (en) | 2000-03-08 |
HUP0002300A2 (hu) | 2001-06-28 |
NO995711L (no) | 2000-01-19 |
BR9809652A (pt) | 2001-09-11 |
SK159299A3 (en) | 2000-06-12 |
WO1998052942A1 (en) | 1998-11-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL143137A0 (en) | Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists | |
IL133036A0 (en) | Quinoline-4-carboxamide derivatives as nk-2 and nk-3 receptor antagonists | |
HK1003884A1 (en) | Quinoline derivatives as tachykinin nk3 receptor and antagonists | |
IL124418A0 (en) | Quinoline-4-carboxamide derivatives their preparation and their use as neurokinin 3 (NK-3)- and neurokinin 2 (NK-2) receptor antagonists | |
CY2505B1 (en) | Quinoline derivatives as nk3 antagonists | |
AP9901459A0 (en) | Tetrahydroquinoline derivatives as eaa antagonists | |
IL132571A0 (en) | Ergoline derivatives and ther use as somatostatin receptor antagonists | |
AU2002215043A1 (en) | Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists | |
EP1248607A4 (en) | UROTENSIN II RECEPTOR ANTAGONISTS | |
PL344694A1 (en) | Tetrahydroquinoline derivatives as glycine antagonists | |
HUP9903480A3 (en) | Indoline derivatives useful as 5-ht-2c receptor antagonists | |
GB9521696D0 (en) | Combination of LTD4 receptor antagonists with glucocorticosteriods | |
AU2002220702A1 (en) | Quinoline derivatives as nk-3 and nk-2 antagonists | |
PL330796A1 (en) | Derivatives of indolin useful as antagonists of 5-ht-2c receptor | |
GB9820014D0 (en) | Receptor antagonists and uses thereof | |
IL142362A0 (en) | Ureidopiperidine derivatives as selective human nk3 receptor antagonists | |
AU2002310838A1 (en) | Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists | |
AU2002308138A1 (en) | 3-substituted quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists | |
HU9603342D0 (en) | Quinoline derivatives as leukotriene antagonists | |
SI0940391T1 (en) | Quinoline derivatives as tachykinin NK3 receptor antagonists | |
SI1003504T1 (en) | Indole derivatives and their use as mcp-1 antagonists | |
SI1086093T1 (sl) | Derivati tetrahidrokinolina kot antagonisti glicina | |
SI1214312T1 (en) | 5-aminoalkyl and 5-aminocarbonyl substituted indoles | |
SI0912556T1 (en) | Indoline derivatives useful as 5-ht-2c receptor antagonists | |
GB9923572D0 (en) | Torch and fuse tester |